Versant Capital Management, Inc
Position in ETON — Eton Pharmaceuticals, Inc.
CIK 1735057
PHOENIX, AZ
Position in ETON
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$2,208
New position
Shares Held
61
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#146
of 164 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names. ETON ranks #24 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,686 | $684,256 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
10,265 | $347,778 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
9,055 | $222,843 | |
| 4 | VTRS |
Viatris Inc
|
11,789 | $187,209 | |
| 5 | HLN |
Haleon plc
|
16,968 | $158,311 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
737 | $124,213 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
182 | $98,613 | |
| 8 | ZTS |
Zoetis Inc.
|
1,244 | $89,393 |
All Filings in ETON
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,208 | 61 | Shares | Sole | 2026-07-02 | |
| No filing history on record for this holder in this stock. | ||||||